CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $9.27 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2019-02-13
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2014-12-27 was $550.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2014-09-27 was $626.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2014-06-28 was $182.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2014-03-29 was $2.94M, a 64.05% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $9.27M, a 12.58% decline from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $10.61M, a 146.64% increase from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $4.30M, a 302.34% increase from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $1.07M, a 755.20% increase from fiscal 2012.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|---|
| 2016-12-31 | $9.27M 10-K · filed 2019-02-13 | |||
| 2015-12-26 | $10.61M 10-K · filed 2018-02-13 | |||
| 2014-12-27 | $550.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $1.18M derived: sum of 2 quarters · filed 2017-02-14 | $1.36M derived: sum of 3 quarters · filed 2017-02-14 | $4.30M 10-K · filed 2017-02-14 |
| 2014-09-27 | $626.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $808.00K derived: sum of 2 quarters · filed 2014-10-30 | $3.75M 10-Q · filed 2014-10-30 | $3.46M derived: sum of 4 quarters · filed 2014-10-30 |
| 2014-06-28 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $3.13M 10-Q · filed 2014-08-07 | $2.83M derived: sum of 3 quarters · filed 2014-08-07 | $2.67M derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-29 | $2.94M 10-Q · filed 2014-04-30 | $2.65M derived: sum of 2 quarters · filed 2014-04-30 | $2.48M derived: sum of 3 quarters · filed 2014-04-30 | $2.22M derived: sum of 4 quarters · filed 2014-04-30 |
| 2013-12-28 | -$293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$458.00K derived: sum of 2 quarters · filed 2014-02-25 | -$725.00K derived: sum of 3 quarters · filed 2014-02-25 | $1.07M 10-K · filed 2014-02-25 |
| 2013-09-28 | -$165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$432.00K derived: sum of 2 quarters · filed 2013-10-30 | $1.36M 10-Q · filed 2013-10-30 | $1.50M derived: sum of 4 quarters · filed 2014-02-25 |
| 2013-06-29 | -$267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $1.53M 10-Q · filed 2013-07-31 | $1.66M derived: sum of 3 quarters · filed 2014-02-25 | $1.80M derived: sum of 4 quarters · filed 2014-02-25 |
| 2013-03-30 | $1.79M 10-Q · filed 2013-05-08 | $1.93M derived: sum of 2 quarters · filed 2014-02-25 | $2.07M derived: sum of 3 quarters · filed 2014-02-25 | $1.92M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-12-29 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $273.00K derived: sum of 2 quarters · filed 2014-02-25 | $130.00K derived: sum of 3 quarters · filed 2014-02-25 | $125.00K 10-K · filed 2014-02-25 |
| 2012-09-29 | $138.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$5.00K derived: sum of 2 quarters · filed 2012-11-01 | -$10.00K 10-Q · filed 2012-11-01 | $298.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | -$143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$148.00K 10-Q · filed 2012-08-07 | $160.00K derived: sum of 3 quarters · filed 2014-02-25 | -$588.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | -$5.00K 10-Q · filed 2012-05-04 | $303.00K derived: sum of 2 quarters · filed 2014-02-25 | -$445.00K derived: sum of 3 quarters · filed 2014-02-25 | $76.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$440.00K derived: sum of 2 quarters · filed 2014-02-25 | $81.00K derived: sum of 3 quarters · filed 2014-02-25 | -$802.00K 10-K · filed 2014-02-25 |
| 2011-09-24 | -$748.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$227.00K derived: sum of 2 quarters · filed 2011-11-02 | -$1.11M 10-Q · filed 2011-11-02 | -$1.50M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | $521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | -$362.00K 10-Q · filed 2011-08-03 | -$750.00K derived: sum of 3 quarters · filed 2013-02-27 | -$1.15M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | -$883.00K 10-Q · filed 2011-05-04 | -$1.27M derived: sum of 2 quarters · filed 2013-02-27 | -$1.67M derived: sum of 3 quarters · filed 2013-02-27 | |
| 2010-12-25 | -$388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$786.00K derived: sum of 2 quarters · filed 2013-02-27 | -$926.00K 10-K · filed 2013-02-27 | |
| 2010-09-25 | -$398.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$538.00K 10-Q · filed 2011-11-02 | ||
| 2010-06-26 | -$140.00K 10-Q · filed 2011-08-03 | |||
| 2009-12-26 | -$2.20M 10-K · filed 2012-02-27 | |||
| 2008-12-27 | $4.77M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |